Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CASI Pharmaceuticals (CASI) EPS (Weighted Average and Diluted) (2023)

Historic EPS (Weighted Average and Diluted) for Pharmaceuticals (CASI) over the last 1 years, with Q4 2023 value amounting to -$0.25.

  • Pharmaceuticals' EPS (Weighted Average and Diluted) changed N/A to -$0.25 in Q4 2023 from the same period last year, while for Dec 2024 it was -$1.36, marking a year-over-year decrease of 45145.2%. This contributed to the annual value of -$2.48 for FY2024, which is 2285.33% down from last year.
  • According to the latest figures from Q4 2023, Pharmaceuticals' EPS (Weighted Average and Diluted) is -$0.25.
  • Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at -$0.25 for Q4 2023, and its period low was -$0.25 during Q4 2023.